Industry Perspectives and Commercialization
This session focuses on bridging the gap between scientific discovery and market-ready regenerative medicine solutions. It will explore the industrial landscape of tissue science, including biotechnology startups, pharmaceutical developments, and medical device innovations. Participants will gain insights into technology transfer processes, intellectual property management, regulatory strategies, and commercialization pathways for regenerative therapies. The session will also highlight challenges in scaling up laboratory innovations into viable clinical and commercial products, including manufacturing standards, cost considerations, and global market access. Discussions will include public-private partnerships, venture capital funding, and entrepreneurship opportunities in life sciences. Case studies of successful commercialization of regenerative technologies will be presented to provide practical insights. By bringing together researchers, investors, industry leaders, and policymakers, this session aims to promote innovation-driven growth and accelerate the translation of regenerative medicine from bench to market.